As shown by immunohistochemical examination in Figure 1A, 10% of patients with gastric cancer had strong NELFE protein expression in adjacent tissues, 21% had moderate NELFE expression, 30% had weak NELFE positive expression, and 39% were NELFE negative. The gene discussed is NELFE; the disease is gastric cancer.